Publications dans lesquelles il/elle collabore avec M DESAMPARADOS ESCUDERO GARCIA (22)

2024

  1. Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score

    Liver International, Vol. 44, Núm. 1, pp. 202-213

  2. Improved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity

    Journal of Translational Medicine, Vol. 22, Núm. 1

2023

  1. Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  2. Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

  3. Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease

    Frontiers in Endocrinology, Vol. 14

2022

  1. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease

    Radiology, Vol. 302, Núm. 2, pp. 345-354

  2. Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy

    Scientific Reports, Vol. 12, Núm. 1

  3. Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy

    International Journal of Molecular Sciences, Vol. 23, Núm. 20

  4. Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis

    Journal of Hepatology, Vol. 77, Núm. 6, pp. 1554-1563

2021

  1. A new score unveils a high prevalence of mild cognitive impairment in patients with nonalcoholic fatty liver disease

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  2. Digital pathology enables automated and quantitative assessment of inflammatory activity in patients with chronic liver disease

    Biomolecules, Vol. 11, Núm. 12

  3. Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease

    Alimentary Pharmacology and Therapeutics, Vol. 53, Núm. 1, pp. 160-171

  4. Multi-omic analysis unveils biological pathways in peripheral immune system associated to minimal hepatic encephalopathy appearance in cirrhotic patients

    Scientific Reports, Vol. 11, Núm. 1

  5. Patients with minimal hepatic encephalopathy show altered thermal sensitivity and autonomic function

    Journal of Clinical Medicine, Vol. 10, Núm. 2, pp. 1-18

2020

  1. Motor and cognitive performance in patients with liver cirrhosis with minimal hepatic encephalopathy

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-16

2019

  1. Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy

    Journal of Translational Medicine, Vol. 17, Núm. 1

2018

  1. Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment

    Free Radical Research, Vol. 52, Núm. 1, pp. 118-133

  2. Learning and Memory Impairments in Patients with Minimal Hepatic Encephalopathy are Associated with Structural and Functional Connectivity Alterations in Hippocampus

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Minimal hepatic encephalopathy is associated with expansion and activation of CD4+CD28-, Th22 and Tfh and B lymphocytes

    Scientific Reports, Vol. 7, Núm. 1

  2. Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy

    PLoS ONE, Vol. 12, Núm. 10